首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1439368

氣道支架 - 全球市場回顧、競爭格局、市場預測 (2030)

Airway Stent - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年02月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

預計 2024 年至 2030 年預測期內，全球氣道支架市場規模將以 7.73% 的複合年增長率成長。氣道支架需求的增加主要是由於肺癌和呼吸道疾病的盛行率不斷增加。此外，內視鏡治療、支氣管鏡檢查等治療方法的高採用率以及對微創手術的日益偏好也有望推動該設備的市場成長。此外，即時呼吸資料收集等技術進步預計將加強全球市場，並有助於 2024-2030 年預測期內氣道支架市場的成長。

氣道支架市場動態

在氣道支架市場，由於多種原因，產品需求不斷增加。

全球肺癌和呼吸系統疾病盛行率的增加預計將增強該市場。例如，根據世界衛生組織 (WHO) (2022) 的數據，癌症是全球主要死亡原因，2020 年約有 1,000 萬人死於癌症，約佔死亡人數的六分之一。根據同一數據，預計2020年全球將有近221萬人受到肺癌的影響。肺癌會阻塞部分氣道，導致呼吸困難。將氣道支架插入氣道以保持氣道開放，使呼吸更容易。因此，肺癌盛行率的不斷上升預計將增加對氣道支架的需求，並推動該設備在2022-2028年預測期內的整體市場成長。

此外，許多呼吸道疾病的日益普及增加了市場對產品的需求。例如，氣道支架用於治療氣管支氣管軟化症。這種情況會削弱氣道並使呼吸過程變得困難。這種情況可以透過插入氣道支架來治療。因此，呼吸系統疾病的日益普及可能會增加市場對氣道支架的需求，並加強該設備的整體市場成長。

此外，對微創手術不斷增長的需求和意識預計也將增加對氣道支架的需求，並在 2022-2028 年預測期內增加氣道支架的整體市場成長。

然而，對設備的嚴格監管審批以及偏遠地區缺乏熟練的專業人員可能會阻礙氣道支架市場的成長。

持續的 COVID-19 大流行也對氣道支架市場產生了一些影響。疾病爆發之初，為遏制病毒傳播實施了嚴格的封鎖，導致嚴重短缺。與 COVID-19 患者相比，癌症和其他慢性病患者的住院治療優先順序較低。一些醫療設備的生產也已停止。此外，在大流行期間，手術暫時停止。為了降低 COVID-19 傳播的風險，醫生推遲或取消了半緊急和選擇性病例。然而，隨著大眾接種疫苗，氣道支架市場重新恢復動力。

氣道支架細分市場分析

就氣道支架市場類型而言，預計到 2023 年，氣管支氣管支架將佔據氣道支架市場的主要份額。這可能是由於與氣管支氣管支架相關的各種優點和廣泛的應用。

氣管支氣管支架用於多種適應症，例如肺癌和各種呼吸系統疾病，例如慢性阻塞性肺病（COPD）。例如，根據世界衛生組織 (WHO) 發布的數據（2022 年），慢性阻塞性肺病是世界第三大死因，估計 2019 年已導致 323 萬人死亡。此外，在低收入和中等收入國家，近 90% 的慢性阻塞性肺病死亡發生在 70 歲以下的患者身上。此外，慢性阻塞性肺病會導致持續且進行性的呼吸道症狀，包括呼吸困難、咳嗽和咳痰。慢性阻塞性肺病（COPD）盛行率的不斷增加增加了市場上對氣道支架的需求，因為它們用於治療慢性阻塞性肺病（COPD）症狀。因此，預計上述因素將在預測期內推動該設備的整體市場成長。

本報告提供了全球氣道支架市場的研究和分析，包括市場規模和預測、促進因素和挑戰以及公司和產品概況。

氣道支架市場驅動因素
- 肺癌和呼吸系統疾病的盛行率不斷上升
- 內視鏡治療和支氣管鏡檢查等治療方法的採用率很高，並且對微創手術的偏好日益增加
- 即時呼吸資料收集等技術進步
氣道支架市場的限制因素與挑戰
- 嚴格的設備監管審批
- 偏遠地區缺乏熟練的專業人員
氣道支架市場機遇
- 增加政府對研發活動的資助

第 5 章氣道支架市場波特五力分析

第 5 章COVID-19對氣道支架市場的影響分析

第 7 章氣道支架市場佈局

依類型
- 氣管支氣管支架
- 喉支架
依材料類型
- 金屬支架
- 矽膠支架
- 混合支架
依產品類型
- 自膨脹支架
- 不可擴張支架
按最終用戶
- 醫院
- 門診手術中心
- 其他
按地區
- 北美
- 歐洲
- 亞太地區
- 其他領域

第 8 章氣道支架市場：全球公司份額分析 - 3 至 5 家主要公司

第 9 章氣道支架市場公司及產品概況

Boston Scientific Corporation
TAEWOONG
MICRO-TECH (Nanjing) Co., Ltd.
Novatech SA
Boston Medical Products Inc.
HOOD LABORATORIES.
Merit Medical Systems.
Cook
Meditek Systems Pvt. Ltd.
Stening SRL
Fuji Systems
Olympus
Kapitex Healthcare Ltd
Teleflex Incorporated.
EFER ENDOSCOPY

第 10 章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡資訊

簡介目錄圖表

Product Code: DIMDCL0164

Airway Stents Market By Type (Tracheobronchial Stents And Laryngeal Stents), By Material Type (Metal Stents [Nitinol Stents, Stainless Steel Stents, And Other Metal Stents], Silicone Stents, And Hybrid Stents), By Product Type (Self-Expandable Stents And Non-Expandable Stents), By End-User (Hospitals, Ambulatory Surgical Centers And Others), by geography is expected to grow at a healthy CAGR forecast till 2030 owing to an increasing prevalence of lung cancer and respiratory diseases and rising preference for minimally invasive surgeries

Global airway stents market is expected to grow at a CAGR of 7.73% during the forecast period from 2024 to 2030. The increase in demand for airway stents is primarily attributed to the increasing prevalence of lung cancer and respiratory diseases. Moreover, high adoption of therapeutic treatments such as endoscopic therapy, bronchoscopy, and other treatments and rising preference for minimally invasive surgeries will propel the market growth of the device. Further, the technological advancements such as real-time data collection of the respiratory tract, and other advancements across the world are anticipated to bolster the market, thereby contributing to the growth of the airway stents market during the forecast period from 2024-2030.

Airway Stents Market Dynamics:

The airway stents market is witnessing a growth in product demand owing to various reasons.

The increasing prevalence of lung cancer and respiratory disorders, across the world are anticipated to bolster the market. For instance, according to World Health Organization (WHO) 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. As per the same source, it was estimated that nearly 2.21 million people were suffering from lung cancer globally in the year 2020. Due to the lung cancer, the airway is partly blocked making it difficult for a patient to breathe. Airway stents are inserted in the airway to keep it open, leading to easy breathing. Thus, the increasing prevalence of lung cancer will increase the demand of airway stents, thereby anticipated to propel the overall market growth of the device in the forecast period of 2022 - 2028.

Additionally, increasing prevalence of many respiratory disorders will increase the product demand in the market. For instance, airway stents are used to treat tracheobronchomalacia. In this condition, the airway becomes weak making the breathing process difficult. The condition can be cured by inserting an airway stent. Thus, the increasing prevalence of respiratory disorder may increase the demand of airway stents in the market, bolstering the overall market growth of the device.

Moreover, the increasing demand and awareness of minimally invasive surgeries will also increase the demand of the airway stents, thereby increasing the overall market growth of airway stents in the forecast period of 2022 - 2028.

However, stringent regulatory approvals of the device and the dearth of skilled professionals in remote regions may hamper the airway stents market growth.

The ongoing COVID-19 pandemic has also slightly impacted the market for airway stents. At the onset of the disease, there was a significant shortage, attributed to the imposition of stringent lockdowns to curb the spread of the virus. Hospital admissions for patients that are suffering from cancers and other chronic disorders were not a priority in comparison to the patients suffering from coronavirus. Production of some medical devices was also shut down. Furthermore, the surgeries were temporarily stopped during the pandemic. To reduce the COVID-19 transmission risk, the physician have either postponed or canceled the semi-urgent and elective cases. However, with masses being vaccinated, the airway stents market has picked momentum.

Airway Stents Market Segment Analysis:

Airway stents Market by Type (Tracheobronchial Stents and Laryngeal Stents), by Material Type (Metal Stents [Nitinol Stents, Stainless Steel Stents, and Other Metal Stents], Silicone Stents, and Hybrid Stents), By Product Type (Self-Expandable Stents and Non-Expandable Stents), By End-User (Hospitals, Ambulatory Surgical Centers and Others), By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the airway stents market, the tracheobronchial stents are estimated to hold a significant share in the airway stents market in the year 2023. This can be ascribed to the various advantages and a wide application circle that is associated with tracheobronchial stents.

The tracheobronchial stents are used in various indications like lung cancer and various respiratory disorders such as chronic obstructive pulmonary disorder (COPD). For instance, according to data published by World Health Organization (WHO) 2022, it was estimated that COPD was the third leading cause of death worldwide, causing 3.23 million deaths in the year 2019. Additionally, nearly 90% of COPD deaths were those in patients under 70 years of age in low- and middle-income countries. Moreover, COPD causes persistent and progressive respiratory symptoms, including difficulty in breathing, cough and phlegm production. The increasing prevalence of COPD will increase the demand of airway stents as they are used to treat the COPD symptoms, thereby increasing the demand of the device in the market. Therefore, the above factor is anticipated to propel the overall market growth of the device in the forecast period.

Moreover, the product launches, in turn, drive the product demand in the market. For instance, in February 2022, Micro-Tech Endoscopy, announced that the company has introduced the first self-expanding tracheobronchial nitinol y-stent. The Y-Shaped Tracheal Stent System is designed to be a flexible, and compliant device to aid in the treatment of malignant neoplasms at the tracheobronchial carina.

Thus, owing to the various advantages like high-resolution, larger magnification offered by the electron microscopes and an increase in the launch and approvals of electron microscopes, there will be an increase in the demand for electron microscopes, which in turn will drive the airway stents market growth.

North America is expected to dominate the overall Airway Stents Market:

Among all the regions, North America is estimated to achieve a significant share in the global airway stents market. The increasing prevalence of lung cancer and respiratory diseases and rising preference for minimally invasive surgeries will increase the demand for airway stents in North America, leading to a rise in the overall airway stents market growth.

For instance, as per the data published by Centers for Disease Control and Prevention (CDC) 2020, it was estimated that in the year 2019 in the United States, 221,097 new cases of Lung and Bronchus cancer were reported, and 139,601 people had died of this cancer. As per the same source, it was also concluded that for every 100,000 people, 53 new Lung and Bronchus cancer cases were reported and 33 people died of this cancer. Moreover, as per the CDC study cancer is the second leading cause of death in the United States, exceeded only by heart disease. One of every four deaths in the United States is due to cancer. The increasing prevalence and the mortality rate can be controlled by providing accurate treatment at the relevant stage of the disease. Airway blockage due to lung cancer can be cured by inserting an airway stent. Thus, the increasing prevalence of lung cancer in the region will increase the product demand ultimately propelling the overall market growth in the forecast period of 2022 - 2028.

Moreover, the increasing use of tobacco is one of the major risk factor of lung cancer and for many respiratory disorders. For instance, as per the data given by CDC 2022, it was estimated that in the year 2020, nearly 13 of every 100 U.S. adults aged 18 years or older smoked cigarettes. Additionally, as per the same source, cigarette smoking remains the leading cause of preventable disease, disability, and death in the United States, accounting for more than 480,000 deaths every year, or about 1 in 5 deaths. Thus, the increasing consumption of tobacco may increase the risk of development of lung cancer and respiratory ailments. These disorders can be cured by inserting an airway stents through a surgical procedure. Thus, the increasing prevalence of lung cancer and respiratory disorder will increase the demand of the device in the market thereby, increasing the overall market growth of the airway stents in the North America in the year 2023 - 2028.

Thus, all the above-mentioned factors are anticipated to propel the market for airway stents in the North America.

Airway Stents Market Key Players:

Some of the key market players operating in the airway stents market include Boston Scientific Corporation, TAEWOONG, MICRO-TECH (Nanjing) Co., Ltd., Novatech SA, Boston Medical Products Inc., HOOD LABORATORIES., Merit Medical Systems., Cook, Meditek Systems Pvt. Ltd., Stening SRL, Fuji Systems, Olympus, Kapitex Healthcare Ltd, Teleflex Incorporated., EFER ENDOSCOPY, among others.

Recent Developmental Activities in the Airway Stents Market:

In January 2020, The U.S. Food and Drug Administration has cleared 3D-printed, patient-specific airway stents developed by Cleveland Clinic's, a nonprofit American academic medical center based in Cleveland, Ohio.

Key Takeaways from the Airway Stents Market Report Study

Market size analysis for current airway stents market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the airway stents market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the global airway stents market.
Various opportunities available for the other competitor in the airway stents market space.
What are the top performing segments in 2023? How these segments will perform in 2030.
Which is the top-performing regions and countries in the current airway stents market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for airway stents market growth in the coming future?

Target Audience who can be benefited from this Airway Stents Market Report Study

Airway stents products providers
Research organizations and consulting companies
Airway stents-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in airway stents
Various End-users who want to know more about the airway stents market and latest technological developments in the airway stents market.

Frequently Asked Questions for Airway Stents Market:

1. What are Airway stents?

An airway stents, also known as tracheobronchial prostheses, is a medical device with tube-shape and a hollow lumen that is inserted into an airway. They are usually placed bronchoscopically and can be used to treat a variety of large airway diseases.

2. What is the market for Global Airway stents?

Global airway stents market is expected to grow at a CAGR of 7.73% during the forecast period from 2024 to 2030.

3. What are the drivers for the Global Airway stents Market?

The airway stents market is witnessing a positive market growth owing to the increasing prevalence of lung cancer and respiratory diseases. Additionally, high adoption of therapeutic treatments such as endoscopic therapy, bronchoscopy, and other treatments and rising preference for minimally invasive surgeries will propel the market growth of the device. Furthermore, the technological advancements such as real-time data collection of the respiratory tract across the world are anticipated to bolster the market.

4. Who are the key players operating in the Global Airway stents Market?

5. Which region has the highest share in Airway stents Market?

North America is expected to hold the highest share in the revenue in the airway stents market during the forecast period. Increasing prevalence of lung cancer and respiratory diseases and rising preference for minimally invasive surgeries will increase the demand for airway stents in North America, leading to a rise in the overall airway stents market growth in this region.

1.Airway stents Market Report Introduction

2.Airway stents Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
2.4. Financial Benchmarking

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Airway stents Market Key Factors Analysis

4.1. Airway stents Market Drivers
- 4.1.1. Increasing prevalence of lung cancer and respiratory diseases
- 4.1.2. High adoption of therapeutic treatments such as endoscopic therapy, bronchoscopy, and other treatments and rising preference for minimally invasive surgeries
- 4.1.3. The technological advancements such as real-time data collection of the respiratory tract
4.2. Airway stents Market Restraints and Challenges
- 4.2.1. Stringent regulatory approvals of the device
- 4.2.2. Dearth of skilled professionals in remote regions
4.3. Airway stents Market Opportunities
- 4.3.1. Increased government funding for research and developmental activities

5. Airway stents Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Airway stents Market

7. Airway stents Market Layout

7.1. By Type
- 7.1.1. Tracheobronchial Stents
- 7.1.2. Laryngeal Stents
7.2. By Material Type
- 7.2.1. Metal Stents
  - 7.2.1.1. Nitinol Stents
  - 7.2.1.2. Stainless Steel Stents
  - 7.2.1.3. Other Metal Stents
- 7.2.2. Silicone Stents
- 7.2.3. Hybrid Stents
7.3. By Product Type
- 7.3.1. Self-expandable Stents
- 7.3.2. Non-expandable Stents
7.4. By End User
- 7.4.1. Hospitals
- 7.4.2. Ambulatory Surgical Centers
- 7.4.3. Others
7.5. By Geography
- 7.5.1. North America
  - 7.5.1.1. North America Airway stents Market, by Country
  - 7.5.1.1.1. United States
  - 7.5.1.1.2. Canada
  - 7.5.1.1.3. Mexico
- 7.5.2. Europe
  - 7.5.2.1. Europe Airway stents Market, by Country
  - 7.5.2.1.1. France
  - 7.5.2.1.2. Germany
  - 7.5.2.1.3. United Kingdom
  - 7.5.2.1.4. Italy
  - 7.5.2.1.5. Spain
  - 7.5.2.1.6. Russia
  - 7.5.2.1.7. Rest of Europe
- 7.5.3. Asia-Pacific
  - 7.5.3.1. Asia-Pacific Airway stents Market, by Country
  - 7.5.3.1.1. China
  - 7.5.3.1.2. Japan
  - 7.5.3.1.3. India
  - 7.5.3.1.4. Australia
  - 7.5.3.1.5. South Korea
  - 7.5.3.1.6. Rest of Asia Pacific
- 7.5.4. Rest of the World (RoW)
  - 7.5.4.1. RoW Airway stents Market, by Region
  - 7.5.4.1.1. Middle East
  - 7.5.4.1.2. Africa
  - 7.5.4.1.3. South America

8. Airway stents Market Global Company Share Analysis - Key 3-5 Companies

9. Airway stents Market Company and Product Profiles

9.1. Boston Scientific Corporation
- 9.1.1. Company Overview
- 9.1.2. Company Snapshot
- 9.1.3. Financial Overview
- 9.1.4. Product Listing
- 9.1.5. Entropy
9.2. TAEWOONG
- 9.2.1. Company Overview
- 9.2.2. Company Snapshot
- 9.2.3. Financial Overview
- 9.2.4. Product Listing
- 9.2.5. Entropy
9.3. MICRO-TECH (Nanjing) Co., Ltd.
- 9.3.1. Company Overview
- 9.3.2. Company Snapshot
- 9.3.3. Financial Overview
- 9.3.4. Product Listing
- 9.3.5. Entropy
9.4. Novatech SA
- 9.4.1. Company Overview
- 9.4.2. Company Snapshot
- 9.4.3. Financial Overview
- 9.4.4. Product Listing
- 9.4.5. Entropy
9.5. Boston Medical Products Inc.
- 9.5.1. Company Overview
- 9.5.2. Company Snapshot
- 9.5.3. Financial Overview
- 9.5.4. Product Listing
- 9.5.5. Entropy
9.6. HOOD LABORATORIES.
- 9.6.1. Company Overview
- 9.6.2. Company Snapshot
- 9.6.3. Financial Overview
- 9.6.4. Product Listing
- 9.6.5. Entropy
9.7. Merit Medical Systems.
- 9.7.1. Company Overview
- 9.7.2. Company Snapshot
- 9.7.3. Financial Overview
- 9.7.4. Product Listing
- 9.7.5. Entropy
9.8. Cook
- 9.8.1. Company Overview
- 9.8.2. Company Snapshot
- 9.8.3. Financial Overview
- 9.8.4. Product Listing
- 9.8.5. Entropy
9.9. Meditek Systems Pvt. Ltd.
- 9.9.1. Company Overview
- 9.9.2. Company Snapshot
- 9.9.3. Financial Overview
- 9.9.4. Product Listing
- 9.9.5. Entropy
9.10. Stening SRL
- 9.10.1. Company Overview
- 9.10.2. Company Snapshot
- 9.10.3. Financial Overview
- 9.10.4. Product Listing
- 9.10.5. Entropy
9.11. Fuji Systems
- 9.11.1. Company Overview
- 9.11.2. Company Snapshot
- 9.11.3. Financial Overview
- 9.11.4. Product Listing
- 9.11.5. Entropy
9.12. Olympus
- 9.12.1. Company Overview
- 9.12.2. Company Snapshot
- 9.12.3. Financial Overview
- 9.12.4. Product Listing
- 9.12.5. Entropy
9.13. Kapitex Healthcare Ltd
- 9.13.1. Company Overview
- 9.13.2. Company Snapshot
- 9.13.3. Financial Overview
- 9.13.4. Product Listing
- 9.13.5. Entropy
9.14. Teleflex Incorporated.
- 9.14.1. Company Overview
- 9.14.2. Company Snapshot
- 9.14.3. Financial Overview
- 9.14.4. Product Listing
- 9.14.5. Entropy
9.15. EFER ENDOSCOPY
- 9.15.1. Company Overview
- 9.15.2. Company Snapshot
- 9.15.3. Financial Overview
- 9.15.4. Product Listing
- 9.15.5. Entropy